Barclays Maintains Underweight on Rackspace Tech, Lowers Price Target to $4

Barclays analyst Ramsey El-Assal maintains Rackspace Tech (NASDAQ:RXT) with a Underweight and lowers the price target from $5 to $4.

byBenzinga Newsdesk

October 3, 2022

1 minute read

Barclays analyst Ramsey El-Assal maintains Rackspace Tech (NASDAQ:RXT) with a Underweight and lowers the price target from $5 to $4.

Barclays Maintains Equal-Weight on Qualcomm, Lowers Price Target to $120

By Benzinga Newsdesk

Today, 3:28 PM

Barclays analyst Blayne Curtis maintains Qualcomm (NASDAQ:QCOM) with a Equal-Weight and lowers the price target from $160 to $120.

QCOM

JP Morgan Maintains Neutral on Blackstone Mortgage Trust, Lowers Price Target to $27.5

By Benzinga Newsdesk

Today, 3:28 PM

JP Morgan analyst Richard Shane maintains Blackstone Mortgage Trust (NYSE:BXMT) with a Neutral and lowers the price target from $30 to $27.5.

BXMT

Credit Suisse Lists Reason Behind Its Bullishness On Amazon Ahead Of Q1

By Anusuya Lahiri

Today, 3:28 PM

Credit Suisse reiterated its Outperform rating on Amazon.com Inc (NASDAQ:AMZN), leaving its price target unchanged at $4,100 (38.3% upside) ahead of its…

AMZN

Ascend Wellness Net Revenue Increased +28% YoY, Q1 2022 Financial Results And MedMen Settlement

By Nicolas Jose Rodriguez

Today, 3:28 PM

Ascend Wellness Holdings, Inc. (CSE: AAWH.U) (OTCQX: AAWH), a vertically integrated multi-state cannabis operator, on Wednesday, reported its financial results for the three months ended March 31, 2022.

AAWH

Barclays Maintains Underweight on Rackspace Tech, Lowers Price Target to $4

Related Posts

Barclays Maintains Equal-Weight on Qualcomm, Lowers Price Target to $120

JP Morgan Maintains Neutral on Blackstone Mortgage Trust, Lowers Price Target to $27.5

Credit Suisse Lists Reason Behind Its Bullishness On Amazon Ahead Of Q1

Ascend Wellness Net Revenue Increased +28% YoY, Q1 2022 Financial Results And MedMen Settlement